SimuSkin™ is the result of Simulab's persistent efforts in research and development. SimuSkin™ has been meticulously designed to emulate human tissue with accuracy in appearance, feel, tactile, and ...

SEATTLE, WA / ACCESSWIRE / August 19, 2024 / Simulab Corporation, a leader in medical simulation technology, is excited to announce the launch of its latest human patient simulator, the AirwayBaby™ ...

SEATTLE, WA / ACCESSWIRE / August 31, 2015 / Seattle-based medical simulator manufacturer, Simulab, announces the release of PICCLineMan, an innovative training simulator designed to provide medical ...

Dublin, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The "Surgical Simulation Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The surgical simulation market is ...

Norfolk, Va. — A first-of-its-kind collaboration between People for the Ethical Treatment of Animals (PETA), Seattle-based medical simulation manufacturer Simulab, and trauma surgeons in nine ...

New Technology in Intravenous Access Training Compatible With Ultrasound Imaging for Realistic Education SEATTLE, WA / ACCESSWIRE / July 23, 2024 / Simulab Corporation, a leading healthcare simulation ...

Surgical Simulation Market is estimated to be valued at USD 480.2 Mn in 2024 and is expected to reach USD 1,332.1 Mn by 2031, exhibiting a CAGR of 15.7%. BURLINGAME, CA, UNITED STATES, January 20, ...

SEATTLE, WA / ACCESSWIRE / January 18, 2024 / Simulab Corporation, a leader in the medical simulation industry headquartered in Seattle, WA, proudly unveils its latest technology - SimuSkin. This ...